We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Lung Ultrasound Used to Manage Critically Ill COVID-19 Patients Leads to Huge Time Savings as Compared to Chest CT

By HospiMedica International staff writers
Posted on 22 Jun 2021
The use of lung ultrasound allows medical personnel to monitor the progress of COVID-19 patients with considerable time savings as compared to traditional radiology, according to new research.

In their study, researchers from the University of Udine (Udine, Italy) calculated the time necessary to perform lung ultrasound in critically ill COVID-19 patients. More...
Lung ultrasound is a well-established diagnostic tool in acute respiratory failure, and it is particularly suited for identification, grading, and follow-up of lung involvement severity. In critically ill COVID-19 patients, lung ultrasound is an alternative to chest radiography, chest CT or electric impedance tomography to quantify pulmonary impairment, follow lung involvement changes, or predict an intensive care unit (ICU) stay of more than 30 days or death.

Since medical personnel involved in the treatment of COVID-19 patients wear special protective equipment, it increases the workload dramatically through temperature imbalance, touch impairment, communication problems, and visual difficulties. In this specific work scenario, lung ultrasound may be seen as an extra task that can be a loss of time. Researchers conducted a study to see if the use of lung ultrasound would allow them to monitor the progress of COVID-19 patients with considerable time savings as compared to traditional radiology. Using a Philips Affiniti 70 G ultrasound machine with a convex probe, the team calculated the lung ultrasound in 25 patients admitted to the COVID-19 ICU and the time needed to perform the exam. For scanning 25 different patients, the median time was 4.2 minutes (IQR 3.6-4.5).

To quantify the saved time, the researchers measured the time necessary to prepare, transport, perform and return from a chest CT scan with all the protective equipment. The team calculated a median time required for 25 chest CT scans of 85 minutes (IQR 78.5- 97.5). The time saved for each patient using lung ultrasound would have been about 80.8 minutes. Therefore, the researchers concluded that using lung ultrasound instead of CT to monitor critically ill patients with COVID-19, can free medical personnel to perform other duties.

Additionally, the researchers noted that while repeat CT scans may be impractical and unsafe for patients and operators, lung ultrasound may be the default imaging modality for monitoring patients' conditions throughout their hospital stay and after discharge. However, they cautioned that the use of lung ultrasound does not replace the CT scan, which is necessary to exclude pulmonary or cardiovascular complications in case of the clinical worsening of the patient. Ultimately, the researchers performed a daily topographic ultrasound evaluation of the lung without moving the patient, thereby reducing the number of chest X-rays and CT scans and saving considerable time.

Related Links:
University of Udine


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Glucose Meter
StatStrip®
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.